首页> 外文会议>International symposium on controlled release of bioactive materials;Consumer diversified products conference >EMPLOYMENT OF LAMBDA CARRAGEENAN COMPLEXES IN CONTROLLED RELEASE TABLET FORMULATIONS
【24h】

EMPLOYMENT OF LAMBDA CARRAGEENAN COMPLEXES IN CONTROLLED RELEASE TABLET FORMULATIONS

机译:Lambda角叉菜胶复合物在受控释放片剂配方中的应用

获取原文

摘要

Controlled release formulations were obtained based on complexes between lambda carrageenan and three basic drugs: Metoprolol tartrate, Tramadol HC1 and Bupropion HC1. For all the drugs considered the release was completed in about 10-12 hours, although different kinetics were observed depending on the solubility of the complexes.
机译:基于Lambda角架蛋白烷和三种碱性药物之间的络合物获得控制的释放制剂:美容托洛醇,曲马多HC1和Bupropion HC1。对于所考虑的所有药物,释放在约10-12小时内完成,尽管根据复合物的溶解度观察到不同的动力学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号